Journal article
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial
Abstract
OBJECTIVE: To determine the efficacy and safety of dalteparin postoperative bridging treatment versus placebo for patients with atrial fibrillation or mechanical heart valves when warfarin is temporarily interrupted for a planned procedure.
DESIGN: Prospective, double blind, randomised controlled trial.
Authors
Kovacs MJ; Wells PS; Anderson DR; Lazo-Langner A; Kearon C; Bates SM; Blostein M; Kahn SR; Schulman S; Sabri E
Journal
The BMJ, Vol. 373, ,
Publisher
BMJ
DOI
10.1136/bmj.n1205
ISSN
0959-8138